QA: PDS Biotechnology Corp in us_pharma/2023

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001472091_2024_PDS_Biotechnology_Corp.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001472091, PDS Biotechnology Corp

  xvar xval
0 AssetsCurrent 59,055,075
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 134,132
3 remainder_Assets 200,873
4 LiabilitiesCurrent 13,629,977
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 19,629,156
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 15,282,450
9 ResearchAndDevelopmentExpense 27,762,784
10 remainder_Expenses -1,406,019
11 remainder_Revenues 0
12 remainder_NetIncome -1,302,983
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 59,390,080
1 Liabilities 33,259,133
2 Expenses 41,639,215
3 Revenues 0
4 StockholdersEquity 26,130,947
5 NetIncome -42,942,198
6 ComprehensiveNetIncome -42,942,198
7 BaseVar 67,795,706
8 EconomicCapitalRatiobeforeLimitedLiability 0.303
9 EconomicCapitalRatio 1.70

Edgar->Model Mapping

Feature Distribution

Change over Time